COVID19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability

Authors

  • Scott Spreat
  • Tiffany Adams Woods Services
  • Darlene Barnes Woods Services
  • Jennifer Caputo Woods Services
  • Dawn Diamond Woods Services
  • Tine Woods Services
  • Deborah Jones Woods Services
  • Stephen Kolesk Woods Services

Keywords:

covid-19; antibodies;

Abstract

Approximately 20% of the residential census at a population healthcare facility tested positive for COVID19 during the period from March 2020 through early June 2020. Individuals residing within the facility had intellectual disability, autism, and/or brain injury.   Fifteen were hospitalized, but all subsequently were discharged.  Two hospitalized clients died as a result of factors unrelated to COVID-19, aned a third was pronounced dead upon arrival at the Emergency room, again as a result of factors unrelated to COVID-19.  individuals died as a result of factors unrelated to COVID-19.  Approximately ¾ of the infected clients developed antibodies within 28 days of initial diagnosis.  The development of antibodies could not be predicted from readily available demographic or medical variables

Downloads

Published

2020-09-18

How to Cite

Spreat, S. ., Adams, T., Barnes, D., Caputo, J., Diamond, D. ., Hansen-Turton, T., Jones, D., & Kolesk, S. (2020). COVID19 Prevalence and Antibody Seroprevalence Among Individuals with Intellectual Disability . Social Innovations Journal, 3. Retrieved from https://socialinnovationsjournal.com/index.php/sij/article/view/538